Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	5,866	3,739	2,047	1,254	1,132	2,590
Market Cap Growth	123.85%	82.62%	63.27%	10.73%	-56.28%	61.95%
Enterprise Value	5,579	3,457	1,798	1,090	1,008	2,573
Last Close Price	296.10	189.07	107.15	71.42	66.80	154.46

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	39.67	30.84	-	24.29	-	46.66
Forward PE	54.47	35.20	53.58	35.07	298.37	298.37
PEG Ratio	2.93	2.42	3.57	2.34	23.42	18.19
PS Ratio	21.52	13.95	12.25	9.55	5.77	10.72
PB Ratio	5.97	3.68	2.47	1.79	1.90	3.15
P/TBV Ratio	8.90	5.56	4.27	4.26	7.54	7.86
P/FCF Ratio	48.01	76.44	21.50	27.22	9.44	36.98
P/OCF Ratio	47.83	75.74	21.10	25.29	8.21	32.87

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	20.33	12.89	10.76	8.30	5.14	10.65
EV/EBITDA Ratio	41.63	46.23	142.34	23.51	18.48	16.61
EV/EBIT Ratio	55.36	84.30	-	110.96	331.97	24.78
EV/FCF Ratio	45.35	70.68	18.88	23.66	8.41	36.74

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.45	0.44	0.01	0.01	0.02	0.39
Debt / EBITDA Ratio	3.37	6.04	0.56	0.13	1.61	2.09
Debt / FCF Ratio	3.67	9.23	0.07	0.13	0.73	4.63
Net Debt / Equity Ratio	-0.33	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	-2.44	-3.77	-19.72	-3.54	-2.27	-0.11
Net Debt / FCF Ratio	-2.66	-5.77	-2.62	-3.56	-1.03	-0.24
Asset Turnover	0.18	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	1.16	1.25	0.58	0.56	2.60	2.31
Quick Ratio	20.48	21.18	7.94	12.11	2.45	10.24
Current Ratio	21.28	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	23.36%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	7.52%	3.95%	-4.89%	1.45%	0.63%	7.20%
Return on Invested Capital (ROIC)	16.55%	7.51%	-7.56%	2.22%	1.02%	12.29%
Return on Capital Employed (ROCE)	6.69%	3.38%	-2.70%	1.37%	0.32%	8.25%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.60%	3.24%	-	4.12%	-	2.14%
FCF Yield	2.08%	1.31%	4.65%	3.67%	10.59%	2.70%
Buyback Yield / Dilution	-9.71%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%
Total Shareholder Return	-9.71%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 8, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error